Estonia strengthened its digital ties with the Kingdom of Saudi Arabia (KSA) as the Estonian business delegation, together with Minister of Justice and Digital Affairs Liisa-Ly Pakosta, visited the ...

Connect, the leader in delivering the world's most advanced automated marketing, leasing, and resident engagement platform for multifamily communities across the globe, announced today the receipt of ...

Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. But so far, the company is ...

Bristol Myers Squibb said it is disappointed with the outcome of a study that examined whether one of its drugs could be used to treat a certain type of skin cancer. The drug, Opdualag ...

A Bristol Myers Squibb immunotherapy currently approved as a first-line treatment for metastatic melanoma has failed a pivotal clinical trial intended to support expanding the therapy’s use to ...

The company sates: “Bristol Myers (BMY) Squibb announced the Phase 3 RELATIVITY-098 trial evaluating Opdualag (nivolumab and relatlimab-rmbw) for the adjuvant treatment of patients with ...

A viewer called to ask about Bristol-Myers Squibb Company (NYSE:BMY) and if they should hold it. This is what Cramer had to say: “No, no, you don’t hold it. You buy more. This COBENFY is this ...

Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Saudi Arabia is open to mediating between the Trump administration and Iran in pursuit of a new deal to limit Tehran’s nuclear program, CNN has learned. The kingdom is concerned that Iran may be ...